Variant report
Variant | esv3370394 |
---|---|
Chromosome Location | chr16:31234476-31237024 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:2)
- CpG islands (count:244)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:2 , 50 per page) page:
1
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr16:31235535-31235585 | HCT-116 | colon: | n/a |
2 | chr16:31236039-31236089 | PFSK-1 | brain: | n/a |
3 | chr16:31236039-31236089 | HepG2 | liver: | n/a |
4 | chr16:31235706-31235756 | NT2-D1 | testis: | n/a |
5 | chr16:31235535-31235585 | AoSMC | blood vessel: | n/a |
6 | chr16:31235706-31235756 | T-47D | breast: | n/a |
7 | chr16:31235824-31235874 | GM12891 | blood: | n/a |
8 | chr16:31235824-31235874 | NT2-D1 | testis: | n/a |
9 | chr16:31235706-31235756 | ovcar-3 | ovarian: | n/a |
10 | chr16:31235706-31235756 | AG04450 | lung: | fetal |
11 | chr16:31235824-31235874 | SKMC | muscle: | n/a |
12 | chr16:31236039-31236089 | SKMC | muscle: | n/a |
13 | chr16:31235535-31235585 | CMK | blood: | n/a |
14 | chr16:31235535-31235585 | T-47D | breast: | n/a |
15 | chr16:31235535-31235585 | NT2-D1 | testis: | n/a |
16 | chr16:31235535-31235585 | HUVEC | blood vessel: | n/a |
17 | chr16:31236039-31236089 | HNPCEpiC | eye: | n/a |
18 | chr16:31236039-31236089 | Hela-S3 | cervix: | n/a |
19 | chr16:31235535-31235585 | GM12892 | blood: | n/a |
20 | chr16:31235824-31235874 | Hela-S3 | cervix: | n/a |
21 | chr16:31235535-31235585 | AG09319 | gingival: | n/a |
22 | chr16:31236039-31236089 | HCT-116 | colon: | n/a |
23 | chr16:31235535-31235585 | K562 | blood: | n/a |
24 | chr16:31236039-31236089 | RPTEC | kidney: | n/a |
25 | chr16:31235706-31235756 | RPTEC | kidney: | n/a |
26 | chr16:31236039-31236089 | NHDF-neo | bronchial: | n/a |
27 | chr16:31235706-31235756 | GM12878 | blood: | n/a |
28 | chr16:31236039-31236089 | T-47D | breast: | n/a |
29 | chr16:31235824-31235874 | HCF | heart: | n/a |
30 | chr16:31235824-31235874 | T-47D | breast: | n/a |
31 | chr16:31236039-31236089 | HCM | heart: | n/a |
32 | chr16:31236039-31236089 | BE2_C | brain: | n/a |
33 | chr16:31236039-31236089 | HMEC | breast: | n/a |
34 | chr16:31235824-31235874 | ovcar-3 | ovarian: | n/a |
35 | chr16:31235535-31235585 | HRE | kidney: | n/a |
36 | chr16:31235706-31235756 | HMEC | breast: | n/a |
37 | chr16:31235535-31235585 | ovcar-3 | ovarian: | n/a |
38 | chr16:31235706-31235756 | Jurkat | blood: | n/a |
39 | chr16:31235824-31235874 | NB4 | blood: | n/a |
40 | chr16:31235706-31235756 | HL-60 | blood: | n/a |
41 | chr16:31235824-31235874 | Hepatocyte | liver: | n/a |
42 | chr16:31236039-31236089 | HL-60 | blood: | n/a |
43 | chr16:31235706-31235756 | LNCaP | prostate: | n/a |
44 | chr16:31235824-31235874 | GM19239 | blood: | n/a |
45 | chr16:31235706-31235756 | AG09319 | gingival: | n/a |
46 | chr16:31235535-31235585 | Jurkat | blood: | n/a |
47 | chr16:31235824-31235874 | AG04449 | skin: | fetal |
48 | chr16:31235824-31235874 | Caco-2 | colon: | n/a |
49 | chr16:31235706-31235756 | AoSMC | blood vessel: | n/a |
50 | chr16:31235706-31235756 | NH-A | brain: | n/a |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr16:31231842..31234497-chr16:31258086..31260993,2 | K562 | blood: | |
2 | chr16:31229524..31232280-chr16:31234140..31236879,3 | MCF-7 | breast: | |
3 | chr16:31225061..31229339-chr16:31234222..31239323,4 | MCF-7 | breast: | |
4 | chr16:31228568..31232083-chr16:31234604..31238425,4 | K562 | blood: | |
5 | chr16:31190075..31193214-chr16:31233435..31236932,3 | MCF-7 | breast: | |
6 | chr16:31202771..31204452-chr16:31233343..31235697,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000261925 | TF binding region |
ENSG00000261925 | CpG island |
ENSG00000089280 | chromatin interactions |
ENSG00000177238 | chromatin interactions |
ENSG00000169900 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs538283569 | chr16:31234494-31234495 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
2 | rs567583125 | chr16:31234507-31234508 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
3 | rs550239889 | chr16:31234508-31234509 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
4 | rs568824480 | chr16:31234511-31234512 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
5 | rs189942125 | chr16:31234515-31234516 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
6 | rs377028054 | chr16:31234537-31234538 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
7 | rs370044605 | chr16:31234557-31234558 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
8 | rs144939097 | chr16:31234575-31234576 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
9 | rs567098482 | chr16:31234599-31234600 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
10 | rs73532246 | chr16:31234600-31234601 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs149043964 | chr16:31234708-31234709 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
12 | rs531504689 | chr16:31234710-31234711 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
13 | rs577285903 | chr16:31234725-31234726 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
14 | rs566724550 | chr16:31234824-31234825 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
15 | rs370400734 | chr16:31234825-31234826 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
16 | rs61511265 | chr16:31234842-31234843 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
17 | rs59532700 | chr16:31234972-31234973 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs141450121 | chr16:31234991-31234992 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
19 | rs574801842 | chr16:31234995-31234996 | Weak transcription Strong transcription Genic enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
20 | rs71374053 | chr16:31235063-31235064 | Weak transcription Strong transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
21 | rs386384608 | chr16:31235064-31235065 | Weak transcription Strong transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
22 | rs542314597 | chr16:31235066-31235067 | Weak transcription Strong transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
23 | rs376506088 | chr16:31235068-31235069 | Weak transcription Strong transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
24 | rs537763280 | chr16:31235078-31235079 | Weak transcription Strong transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
25 | rs573394944 | chr16:31235098-31235099 | Weak transcription Strong transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
26 | rs556009645 | chr16:31235099-31235100 | Weak transcription Strong transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
27 | rs373328662 | chr16:31235117-31235118 | Weak transcription Strong transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
28 | rs564864205 | chr16:31235125-31235126 | Weak transcription Strong transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
29 | rs35047843 | chr16:31235177-31235178 | Weak transcription Strong transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
30 | rs532288344 | chr16:31235221-31235222 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
31 | rs182576981 | chr16:31235227-31235228 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
32 | rs186850818 | chr16:31235228-31235229 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
33 | rs532280596 | chr16:31235325-31235326 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
34 | rs529749062 | chr16:31235390-31235391 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
35 | rs56996824 | chr16:31235450-31235451 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
36 | rs368260037 | chr16:31235463-31235464 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
37 | rs547416320 | chr16:31235474-31235475 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
38 | rs548304381 | chr16:31235476-31235477 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
39 | rs200555243 | chr16:31235515-31235516 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
40 | rs150087468 | chr16:31235517-31235518 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
41 | rs534421116 | chr16:31235525-31235526 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
42 | rs58585879 | chr16:31235548-31235549 | Weak transcription Enhancers Strong transcription | CpG islandChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs368859412 | chr16:31235568-31235569 | Weak transcription Enhancers Strong transcription | CpG islandChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
44 | rs372288148 | chr16:31235572-31235573 | Weak transcription Enhancers Strong transcription | CpG islandChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
45 | rs141229511 | chr16:31235579-31235580 | Weak transcription Enhancers Strong transcription | CpG islandChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
46 | rs375350426 | chr16:31235596-31235597 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
47 | rs571127764 | chr16:31235598-31235599 | Weak transcription Enhancers Strong transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
48 | rs372493107 | chr16:31235605-31235606 | Weak transcription Genic enhancers Strong transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
49 | rs112486041 | chr16:31235609-31235610 | Weak transcription Genic enhancers Strong transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
50 | rs375401025 | chr16:31235634-31235635 | Weak transcription Genic enhancers Strong transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Hodgkin''s lymphoma | 20651079 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 16608533 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Autism | 22566537 | CNVD |
Intellectual disability | 22566537 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Lung cancer | 18438408 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Mental retardation | 19951919 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Bladder cancer | 21909424 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21785460 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21990379 | CNVD |
Astrocytoma | 22246337 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Epilepsy | 22499536 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 22513405 | CNVD |
Autism | 22958593 | CNVD |
Autism | 18184952 | CNVD |
Autism | 19966786 | CNVD |
Autism | 21394203 | CNVD |
Autism | 21969575 | CNVD |
Autism | 22241247 | CNVD |
Autism | 20970697 | CNVD |
Autism | 20942916 | CNVD |
Epilepsy | 20970697 | CNVD |
Intellectual disability | 22045946 | CNVD |
Mental retardation | 19966786 | CNVD |
Developmental delay | 20808231 | CNVD |
Obesity | 20808231 | CNVD |
Autism | 18923514 | CNVD |
Obesity | 21881559 | CNVD |
Obesity | 21956041 | CNVD |
Autism | 20659124 | CNVD |
Mental retardation | 21062444 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 21285140 | CNVD |
Schizophrenia | 22885689 | CNVD |
Schizophrenia | 20553308 | CNVD |
Schizophrenia | 20970697 | CNVD |
Schizophrenia | 20433910 | CNVD |
Schizophrenia | 22241247 | CNVD |
Autism | 19242545 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Schizophrenia | 21399695 | CNVD |
Autism | 21956041 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Autism | 22067053 | CNVD |
Autism | 18156158 | CNVD |
Mental retardation | 20152051 | CNVD |
Autism | 19218893 | CNVD |
Autism | 21289514 | CNVD |
Schizophrenia | 19855392 | CNVD |
neurodevelopmental Syndrome | 20503337 | CNVD |
Benign familial neonatal-infantile seizures | 21060786 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Cancer | 21183584 | CNVD |
Low-grade fibromyxoid sarcoma | 21536545 | CNVD |
Breast cancer | 21045282 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Autism | 19050728 | CNVD |
Epilepsy | 20923578 | CNVD |
Psychiatric disorder | 19050728 | CNVD |
Schizophrenia | 19348701 | CNVD |
Attention deficit hyperactivity disorder | 19097825 | CNVD |
Autism | 20964600 | CNVD |
Schizophrenia | 19955444 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 19571808 | CNVD |
Breast cancer | 20409316 | CNVD |
Severe combined immunodeficiency | 19097825 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Autism | 18522746 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Prostate cancer | 18632612 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Cancer | 17440070 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:31227600-31239600 | Weak transcription | Muscle Satellite Cultured Cells | -- |
2 | chr16:31228400-31240200 | Weak transcription | Right Atrium | heart |
3 | chr16:31228800-31240200 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
4 | chr16:31230400-31238800 | Strong transcription | Fetal Muscle Leg | muscle |
5 | chr16:31231000-31246800 | Weak transcription | Psoas Muscle | Psoas |
6 | chr16:31232800-31236600 | Weak transcription | K562 | blood |
7 | chr16:31233000-31238000 | Weak transcription | Spleen | Spleen |
8 | chr16:31233400-31235600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr16:31234200-31235000 | Strong transcription | Fetal Muscle Trunk | muscle |
10 | chr16:31234200-31235800 | Strong transcription | HSMM | muscle |
11 | chr16:31234400-31234800 | Genic enhancers | Skeletal Muscle Male | skeletal muscle |
12 | chr16:31234400-31235000 | Genic enhancers | Skeletal Muscle Female | skeletal muscle |
13 | chr16:31234400-31235000 | Strong transcription | HSMMtube | muscle |
14 | chr16:31234800-31237600 | Strong transcription | Skeletal Muscle Male | skeletal muscle |
15 | chr16:31235000-31237200 | Weak transcription | Fetal Muscle Trunk | muscle |
16 | chr16:31235000-31237400 | Weak transcription | HSMMtube | muscle |
17 | chr16:31235000-31240200 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
18 | chr16:31235200-31235600 | Enhancers | Fetal Intestine Small | intestine |
19 | chr16:31235600-31236000 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
20 | chr16:31235600-31240600 | Weak transcription | Fetal Intestine Small | intestine |
21 | chr16:31235800-31236800 | Weak transcription | HSMM | muscle |
22 | chr16:31236000-31237400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
23 | chr16:31236600-31237000 | Enhancers | K562 | blood |
24 | chr16:31236800-31238200 | Strong transcription | HSMM | muscle |
25 | chr16:31237000-31239600 | Weak transcription | K562 | blood |